“…18 Demographic, antenatal, intrapartum and 6-8 weeks post-delivery data were gathered from women's and infants' medical records, CBH clinical coding data base, AUSLAB data base and the perinatal data forms. Outcomes planned to be assessed were method of delivery, frequency and type of diabetes, glycaemic control using random blood glucose levels (RBGL) and glycosylated haemoglobin (HbA1c) values, insulin use and dosage, gestation at delivery, birth weight and height, birth head circumference, length of stay of the newborn at the hospital after delivery, Apgar score, neonatal obstetric trauma, hypoxic ischaemic encephalopathy (neonatal neurological manifestations documented in the files), neonatal hypoglycaemia (BGL £ 2.5 mmol ⁄ L), need for IV dextrose, RDS (infants requiring oxygen therapy for >4 h post-delivery and clinical signs of RDS), major congenital malformations, presence of jaundice, the highest recorded bilirubin values, method of feeding and health on discharge (well, dead or ill, the latter being defined as needing close medical follow-up after discharge).…”